Goldenwell Biotech, Inc. — Key Metrics
2 years of history · ending 2024-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
EPS (Diluted)
$-0
Book Value Per Share
$-0
Free Cash Flow Per Share
$-0
Cash Per Share
$0
Revenue Per Share
$0
OCF Per Share
$-0
Return on Equity
-701.7%
Return on Assets
-58.1%
Return on Invested Capital
-75.4%
Debt to Equity
-3.68
Quick Ratio
-93.97
Asset Turnover
0.00
Days Sales Outstanding
0.00
Days Payables Outstanding
0.00
Days Inventory On Hand
850634.93
Cash Conversion Cycle
850634.93
Working Capital
$-2K
Net Current Asset Value
$-271K
Invested Capital
$127K
OCF / Net Income
0.94
FCF / Net Income
0.94
Accruals Ratio (Sloan)
-3.8%
Net Debt
$174K
Net Debt / EBITDA
-1.41
Interest Coverage
-14.65
Cash Coverage
-14.65
Tangible Common Equity
$-47K
TCE / Total Assets
-21.1%
NOPAT
$-97K
Cash ROIC
-95.5%
WC / Revenue
-1338.1%
Asset Growth vs Revenue Growth
90.7%
Stock Price (FY-end)
$0
Market Cap
$20M
P/S Ratio
142446.05
P/B Ratio
68.47
P/TB Ratio
68.47
Enterprise Value
$20M
EV / Sales
143697.74
FCF Yield
-0.6%
Shares Variation (YoY)
0.0%
Beta (5Y)
-0.29
Cost of Equity
3.1%
Cost of Debt (after tax)
3.8%
52W High
$0
52W Low
$0
Trailing Return 1Y
241.3%
F-Score (Piotroski)
3.00
Z-Score (Altman)
33.46
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.